Immucell ICCC
NASDAQ ICCC
$10.44 -0.08 (-0.76%)
As of: Oct 22, 2026 · 1:38 PM EDT

Immucell (ICCC) Interest Coverage Ratio (2023 - 2026)

Updated

Immucell's (ICCC) Interest Coverage Ratio stood at 20.23 in Q2 2026, up 343.2% from 4.56 a year earlier.

Analysis

Immucell (ICCC) Interest Coverage Ratio (2023 - 2026) Analysis & Trends

On a TTM basis, Immucell's Interest Coverage Ratio came in at 5.35 as of Jun 30, 2026, up 68.9% year-over-year; for FY2025, it was 3.34.

  • Across earlier years, Interest Coverage Ratio came in at -2.88 in FY2024, -12.09 in FY2023 and -6.60 in FY2022.
  • The Q2 2026 figure is the highest quarterly Interest Coverage Ratio in data going back to Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,166.06 Bn 1,134.65 Bn 19.71 Bn -
2 Johnson & Johnson 647.92 Bn 567.78 Bn 17.30 Bn 28.50
3 AbbVie 503.35 Bn 476.46 Bn 12.70 Bn -
4 Merck 366.72 Bn 321.10 Bn 12.21 Bn -
5 Novartis Ag 303.08 Bn 267.07 Bn 11.24 Bn 10.28
6 Astrazeneca 269.05 Bn 242.74 Bn 12.86 Bn 7.27
7 Amgen 242.23 Bn 197.63 Bn 7.24 Bn 5.22
8 Gilead Sciences 194.93 Bn 169.12 Bn 6.22 Bn -42.08
9 Pfizer 172.51 Bn 119.15 Bn 10.94 Bn -
10 Immucell 94.64 Mn 72.08 Mn 2.44 Mn 20.23
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.23
Dec 31, 2025 -0.55
Sep 30, 2025 0.15
Jun 30, 2025 4.56
Dec 31, 2024 4.56
Sep 30, 2024 -3.99
Jun 30, 2024 -9.74
Mar 31, 2024 -2.06
Jun 30, 2023 -14.73
Mar 31, 2023 -25.07
API Access

Immucell Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=ICCC&period=max&api_key=YOUR_API_KEY